Guatemala adds to list of countries opposing Gilead’s patent applications on remdesivir
NewsTrials into remdesivir have not demonstrated the impact that many had hoped for, in terms of treating COVID-19 patients, although...
-
“Training the next generation of treatment activists in Central America”
Opinion“Only around half of people living with HIV across Central America have access to life-saving treatment. The picture when it...
Read more about “Training the next generation of treatment activists in Central America”
-
“HIV treatment is not sustainable, you must involve civil society to increase access,” treatment activists in Latin America and the Caribbean tell ViiV Healthcare.
NewsTreatment activists, representing 13 countries in the Latin America and Caribbean region (LACTA), met with ViiV Healthcare in Panama City...
